The synthesis of short-chain alkyl bis(amides) (heptyl-, isoheptyl-, octyl-) and nonylamide derivatives as lipophilic derivatives of methotrexate is reported. Direct amine substitution on methotrexate diethyl ester and a carbodiimide-assisted coupling method were used. The compounds were screened for in-vitro inhibitory activity against bovine liver dihydrofolate reductase and growth inhibition of human lymphoblastoid methotrexate-sensitive and resistant CCRF-CEM cells and erythroleukaemic K562 cells. The lipophilic methotrexate derivatives, despite showing lower activity against methotrexate-sensitive tumour cell lines, maintained similar activity to methotrexate, even against a methotrexate-transport resistant cell subline, since they can penetrate tumour cells by a passive route, by-passing the deficient cellular carrier system for the folates. Increasing the lipophilicity of methotrexate is a possible strategy to overcome the clinical resistance to the drug by tumour cells.

Aliphatic α,γ-bis(Amides) of Methotrexate. Influence of Chain Length on In-vitro Activity Against Sensitive and Resistant Tumour Cells

PIGNATELLO, Rosario;SORRENTI, Valeria;DI GIACOMO, Claudia;PUGLISI, Giovanni
1999-01-01

Abstract

The synthesis of short-chain alkyl bis(amides) (heptyl-, isoheptyl-, octyl-) and nonylamide derivatives as lipophilic derivatives of methotrexate is reported. Direct amine substitution on methotrexate diethyl ester and a carbodiimide-assisted coupling method were used. The compounds were screened for in-vitro inhibitory activity against bovine liver dihydrofolate reductase and growth inhibition of human lymphoblastoid methotrexate-sensitive and resistant CCRF-CEM cells and erythroleukaemic K562 cells. The lipophilic methotrexate derivatives, despite showing lower activity against methotrexate-sensitive tumour cell lines, maintained similar activity to methotrexate, even against a methotrexate-transport resistant cell subline, since they can penetrate tumour cells by a passive route, by-passing the deficient cellular carrier system for the folates. Increasing the lipophilicity of methotrexate is a possible strategy to overcome the clinical resistance to the drug by tumour cells.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/10632
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 38
  • ???jsp.display-item.citation.isi??? ND
social impact